Common variable immunodeficiency (CVID) is a primary immunological disease with variable severity, ranging from mild forms of infections to chronic progressive complications. The hallmark of this ...
A study just published in the journal Microbiome, describes for the first time the intestinal microbiome and metabolome in patients with (genetically acquired) CTLA4 deficiency. CTLA4 is an immune ...
In 2001, Megan Ryan, 46, was diagnosed with common variable immunodeficiency (CVID), one of the most common types of primary immunodeficiency diseases, or PIDDs, which are rare genetic disorders that ...
Leiden, the Netherlands, March 20, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces that the first patient has been dosed in a Phase II, proof ...
Like their causative mutations, pathophysiology and natural history, the clinical presentation of inborn errors of immunity (IEI) varies widely. Nevertheless, some features, above all recurrent and/or ...
In treatment-experienced patients, findings showed Xemfiby exposure was similar between weekly and biweekly dosing. The Food and Drug Administration (FDA) has expanded the approval of Xembify ® ...
When you live with primary immunodeficiency (PI), daily routines, such as going to school, working, and seeing friends and family, can turn into a potential health risk. Because PI is rare and you may ...
Expert Rev Clin Immunol. 2009;5(4):381-390. Several intravenous and subcutaneous Ig (SCIg) preparations are available either in a lyophilized form or as ready-to-use solutions. These products differ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results